A Study of Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney Function

Clinical trial NCT01309438 · COMPLETED

Trial details

NCT number: NCT01309438
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Renal Insufficiency

Start date: 2011-02-01
Primary completion: 2012-03-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.